论文信息 - Phase I study of the anti-VEGFR-3 monoclonal antibody IMC-3C5 in subjects with advanced solid tumors refractory to standard therapy or for which no standard therapy is available. - 字舞流文

Phase I study of the anti-VEGFR-3 monoclonal antibody IMC-3C5 in subjects with advanced solid tumors refractory to standard therapy or for which no standard therapy is available.

L. Benjamin | R. Martell | E. Chiorean | F. Fox | H. Youssoufian | B. Pytowski | A. Morozov | J. Patel | A. Qin | A. Dontabhaktuni | L. Abad | M. Rutstein | C. Kukel | T. Steele | M. Dowd